- What is Immunocore’s role in the fight against devastating diseases?
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies to treat a broad range of diseases including cancer, infection and autoimmune diseases.
- Where is Immunocore located?
Immunocore’s principal offices are located at 92 Park Drive, Milton Park, Abindgon, Oxfordshire OX14 4RY, United Kingdom. The company also has offices at 1 Radnor Corporate Center, 100 Matsonford Road, Suite 100, Radnor, PA 19087 and 9801 Washingtonian Boulevard, Suite 800, Gaithersburg, Maryland 20878, United States.
- Where is Immunocore’s common stock listed and what is the ticker symbol?
Immunocore is listed on the Nasdaq Global Market under the ticker symbol IMCR.
- When did Immunocore go public?
Immunocore began trading common stock shares on the Nasdaq Global Market on February 5, 2021.
- Where can I purchase shares of Immunocore?
To purchase Immunocore shares, you must have an account with a financial intermediary (bank, brokerage firm, online broker, etc.) and place your order through them.
- When is the fiscal year-end for Immunocore?
Immunocore’s fiscal year-end is on December 31.
- Who is Immunocore’s Registrar and how do I contact them?
Computershare Investor Services PLC
The Pavilions
Bridgewater Road
Bristol
BS99 6ZY
Phone: 0370 703 0387- Who is Immunocore’s American Depository Share (“ADS”) bank?
Immunocore’s ADS bank is Citibank, N.A. located at 388 Greenwich Street, New York, New York 10013.
- Who are Immunocore’s independent auditors?
Deloitte LLP
1 Station Square
Cambridge, CB1 2GA
United Kingdom- Who is Immunocore’s outside legal counsel?
Cooley LLP
55 Hudson Yards
New York, New York 10001
(212)479-6000